GRAIL’s Galleri Test Shows Promising Results in Early Cancer Detection for U.S. Veterans
GRAIL’s REFLECTION study on the Galleri multi-cancer early detection test shows promising early results in U.S. veterans.
Read MorePosted by Andy Lundin | Oct 24, 2024 | Cancer |
GRAIL’s REFLECTION study on the Galleri multi-cancer early detection test shows promising early results in U.S. veterans.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Lung Cancer, Molecular Diagnostics |
NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.
Read MorePosted by Andy Lundin | Oct 21, 2024 | Unknown Origin & Other Cancer Types |
Thermo Fisher’s CDx for identifying glioma patients eligible for treatment with Servier Pharmaceuticals’ VORANIGO gets FDA approval.
Read MorePosted by Andy Lundin | Oct 18, 2024 | Cancer |
Researchers are creating a paper-based test that detects cancer’s spread to the central nervous system in the cerebrospinal fluid.
Read MorePosted by Andy Lundin | Oct 17, 2024 | Cancer |
The AI-powered sensor amplifies optical signals in body fluids, enabling non-invasive and rapid cancer diagnosis.
Read More